Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Public Engagement Staff draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.
Similar Posts
Kath Khemicals LLC – 711699 – 09/22/2025
CGMP/Finished Pharmaceuticals/AdulteratedFDA In Brief: FDA issues 57 product-specific guidances, including 19 laying out path for developing generics to hard-to-copy “complex” medicines
FDA is posting 57 product-specific guidances to help industry generate evidence needed to support approval of generic drug applicationsAlembic Pharmaceuticals Limited Units I & II – 05/26-31/2025
Alembic Pharmaceuticals Limited Units I & II – 05/26-31/2025. Country: India. Record Type: 483Institutional Review Board (IRB) Written Procedures
Guidance for institutions and IRBs on IRB written proceduresFDA Approves First Treatment for Children With Menkes Disease
The U.S. Food and Drug Administration today approved the Zycubo (copper histidinate) injection as the first treatment for Menkes disease in pediatric patients.Section 804 Importation Program Policies and Authorizations
FDA has issued policies and taken actions to implement section 804 of the Federal Food, Drug and Cosmetic Act, which allows states and Indian tribes to import certain prescription drugs from Canada. Learn more.